SON V T, KHUE P M, STROBEL M. Penicilliosis and AIDS in Haiphong, Vietnam: Evolution and Predictive Factors of Death[J]. Médecine et Maladies Infectieuses, 2014, 44(11-12): 495-501.
周怡宏, 鲁雁秋, 陈耀凯.艾滋病合并马尔尼菲蓝状菌的诊治现状及研究进展[J].中国真菌学杂志, 2019, 14(5): 308-312.
LE T, WOLBERS M, CHI N H, et al. Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium Marneffei Infection in Ho Chi Minh City, Viet Nam[J]. Clinical Infectious Diseases, 2011, 52(7): 945-952.
HU Y X, ZHANG J M, LI X Q, et al. Penicillium Marneffei Infection: an Emerging Disease in Mainland China[J]. Mycopathologia, 2013,175(1-2): 57-67.
RANJANA K H, PRIYOKUMAR K, SINGH T J, et al. Disseminated Penicillium Marneffei Infection among HIV-Infected Patients in Manipur State, India[J]. Journal of Infection, 2002, 45(4): 268-271.
VANITTANAKOM N, COOPER C R Jr, FISHER M C, et al. Penicillium Marneffei Infection and Recent Advances in the Epidemiology and Molecular Biology Aspects[J]. Clinical Microbiology Reviews, 2006, 19(1): 95-110.
LARSSON M, NGUYEN L H, WERTHEIM H F, et al. Clinical Characteristics and Outcome of Penicillium Marneffei Infection among HIV-infected Patients in Northern Vietnam[J]. AIDS Research and Therapy, 2012, 9(1): 24-1-24-5.
LUO B, SUN J J, CAI R T, et al. Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in Shanghai[J]. Medicine, 2016, 95(21): e3802-1-e3802-8.
JIANG J, MENG S, HUANG S, et al. Effects of Talaromyces Marneffei Infection on Mortality of HIV/AIDS Patients in Southern China: a Retrospective Cohort Study[J]. Clinical Microbiology and Infection, 2019, 25(2): 233-241.
ZHENG J D, GUI X E, CAO Q, et al. A Clinical Study of Acquired Immunodeficiency Syndrome Associated Penicillium Marneffei Infection from a Non-Endemic Area in China[J]. PLoS One, 2015, 10(6): 0130376-1-013037-13.
何小庆, 鲁雁秋, 周怡宏, 等.重庆地区56例AIDS合并播散性马尔尼菲篮状菌病患者临床特征及死亡危险因素分析[J].传染病信息, 2018, 31(6): 521-524.
BULTERYS P L, LE T, QUANG V M, et al. Environmental Predictors and Incubation Period of AIDS-Associated Penicillium Marneffei Infection in Ho Chi Minh City, Vietnam[J]. Clinical Infectious Diseases, 2013, 56(9): 1273-1279.
HILMARSDOTTIR I, COUTELLIER A, ELBAZ J, et al. A French Case of Laboratory-Acquired Disseminated Penicillium Marneffei Infection in a Patient with AIDS[J]. Clinical Infectious Diseases, 1994, 19(2): 357-358.
QIU Y, ZHANG J Q, LIU G N, et al. A Case of Penicillium Marneffei Infection Involving the Main Tracheal Structure[J]. BMC Infectious Diseases, 2014, 14: 242-1-242-6.
HUA X, ZHANG R F, YANG H J, et al. Primary Oral Penicillium Marneffei Infection Diagnosed by PCR-Based Molecular Identification and Transmission Electron Microscopic Observation from Formalin-Fixed Paraffin-Embedded Tissues[J]. Medical Mycology Case Reports, 2013, 2: 15-18.
HERMANS F, OMBELET S, DEGEZELLE K, et al. First-in-Man Observation of Talaromyces Marneffei-Transmission by Organ Transplantation[J]. Mycoses, 2017, 60(3): 213-217.
SAMSON R A, YILMAZ N, HOUBRAKEN J, et al. Phylogeny and Nomenclature of the Genus Talaromyces and Taxa Accommodated in Penicillium Subgenus Biverticillium[J]. Studies in Mycology, 2011, 70: 159-183.
XI L Y, XU X R, LIU W, et al. Differentially Expressed Proteins of Pathogenic Penicillium Marneffei in Yeast and Mycelial Phases[J]. Journal of Medical Microbiology, 2007, 56(3): 298-304.
LIU D H, WEI L L, GUO T, et al. Detection of DOPA-Melanin in the Dimorphic Fungal Pathogen Penicillium Marneffei and Its Effect on Macrophage Phagocytosis in Vitro[J]. PLoS One, 2014, 9(3): 0092610-1-0092610-7.
KUDEKEN N, KAWAKAMI K, SAITO A. CD4+T Cell-Mediated Fatal Hyperinflammatory Reactions in Mice Infected with Penicillium Marneffei[J]. Clinical & Experimental Immunology, 1997,107(3): 468-473.
KUDEKEN N, KAWAKAMI K, KUSANO N, et al. Cell-Mediated Immunity in Host Resistance Against Infection Caused byPenicillium Marneffei[J]. Medical Mycology, 1996, 34(6): 371-378.
QIN Y, LI Y Y, LIU W, et al. Penicillium Marneffei-Stimulated Dendritic Cells Enhance HIV-1 Trans-Infection and Promote Viral Infection by Activating Primary CD4+T Cells[J]. PLoS One, 2011, 6(11): 0027609-1-0027609-10.
CHEN J, SONG W, LIU L, et al. Clinical Characteristics and Prognosis of Penicilliosis among Human Immunodeficiency Virus-Infected Patients in Eastern China[J]. The American Journal of Tropical Medicine and Hygiene, 2017, 96(6): 1350-1354.
李勇, 蒙志好, 苏凌松, 等.艾滋病合并马尔尼菲青霉病256例临床研究[J].中国真菌学杂志, 2009, 4(6): 347-350.
HUANG X W, HE G H, LU S, et al. Role of Rhizomys Pruinosusas a Natural Animal Host of Penicillium Marneffeiin Guangdong, China[J]. Microbial Biotechnology, 2015, 8(4): 659-664.
YOUSUKH A, JUTAVIJITTUM P, PISETPONGSA P, et al. Clinicopathologic Study of Hepatic Penicillium Marneffei in Northern Thailand[J]. Archives of Pathology & Laboratory Medicine, 2004,128(2): 191-194.
黄维, 李勇, 覃善芳, 等. 25例艾滋病合并马尔尼菲篮状菌肺炎的临床分析[J].新发传染病电子杂志, 2019(4): 223-226.
窦艳云, 蒙志好, 卢瑞朝, 等.艾滋病合并马尔尼菲蓝状菌病的临床分析[J].中国现代医药杂志, 2019, 21(5): 25-29.
张云桂, 赵月娟, 李玉叶, 等. 226例艾滋病合并马尔尼菲青霉菌病患者的影像学特征[J].皮肤病与性病, 2016, 38(2): 91-94.
章礽荫, 叶雯, 施裕新, 等.艾滋病合并马尔尼菲青霉菌病与艾滋病合并非霍奇金淋巴瘤累及腹部淋巴结的鉴别诊断[J].中国临床医学, 2018, 25(3): 438-441.
CHAN J F, LAU S K, YUEN K Y, et al. Talaromyces (Penicillium) Marneffei Infection in Non-HIV-Infected Patients[J]. Emerging Microbes & Infections, 2016, 5(1): 1-9.
GHALIGE H S, SAHOO B, SHARMA S, et al. Acute Abdomen due to Penicillium Marneffei: an Indicator of HIV Infection in Manipur State[J]. J Clin Diagn Res, 2014, 8(9): 5-6.
袁明娟, 李四海, 黄彦, 等.艾滋病合并马尔尼菲篮状菌感染者临床影像学分析和疗效评价[J].中华传染病杂志, 2019, 37(1): 41-43.
韦璐, 陈刚, 柯柳.晚期艾滋病合并马尔尼菲青霉菌肺部感染的胸部影像学特征[J].中国现代医学杂志, 2013, 23(19): 101-104.
刘晋新, 唐小平, 江松峰, 等.艾滋病合并马尔尼菲青霉菌感染的胸部影像学表现[J].中华放射学杂志, 2007, 41(3): 239-242.
李由, 彭道杨, 刘金贵, 等.艾滋病合并马尔尼菲青霉病的胸部CT表现[J].海南医学, 2016, 27(15): 2474-2475.
崔涛, 李晶晶, 陈七一, 等.艾滋病合并肺结核及马尔尼菲青霉菌病的纵隔淋巴结肿大CT影像特点研究[J].临床放射学杂志, 2015, 34(11): 1738-1741.
LE T, HONG CHAU T T, KIM CUC N T, et al. AIDS-Associated Cryptococcus Neoformansand Penicillium Marneffei Coinfection: a Therapeutic Dilemma in Resource-Limited Settings[J]. Clinical Infectious Diseases, 2010, 51(9): e65-e68.
覃江龙, 吴念宁, 梁纲.艾滋病合并马尔尼菲青霉菌感染中枢神经系统1例[J].中国热带医学, 2018, 18(4): 410-412.
QIU Y, ZHANG J Q, LIU G N, et al. Retrospective Analysis of 14 Cases of Disseminated Penicillium Marneffei Infection with Osteolytic Lesions[J]. BMC Infectious Diseases, 2015, 15: 47-1-47-7.
KAWILA R, CHAIWARITH R, SUPPARATPINYO K. Clinical and Laboratory Characteristics of Penicilliosis Marneffei Among Patients with and without HIV Infection in Northern Thailand: a Retrospective Study[J]. BMC Infectious Diseases, 2013, 13: 464-1-464-5.
LIU G N, HUANG J S, ZHONG X N, et al. Penicillium Marneffei Infection Within an Osteolytic Lesion in an HIV-Negative Patient[J]. International Journal of Infectious Diseases, 2014, 23: 1-3.
KHIEU C, APIVATTHAKAKUL A, KUNAVISARUT P, et al. Case Report: Bilateral Granulomatous Anterior Uveitis in HIV-Patient with Disseminated Talaromycosis (penicilliosis) Marneffei Infection[J]. Ocular Immunology and Inflammation, 2019: 1-3.
VILAR F J, HUNT R, WILKINS E L, et al. Disseminated Penicillium Marneffei in a Patient Infected with Human Immunodeficiency Virus[J]. International Journal of STD & AIDS, 2000, 11(2): 126-128.
SUPPARATPINYO K, KHAMWAN C, BAOSOUNG V, et al. Disseminated Penicillium Marneffei Infection in Southeast Asia[J]. The Lancet, 1994,344(8915): 110-113.
LIMPER A H, ADENIS A, LE T, et al. Fungal Infections in HIV/AIDS[J]. The Lancet Infectious Diseases, 2017, 17(11): e334-e343.
NING C Y, LAI J Z, WEI W D, et al. Accuracy of Rapid Diagnosis of Talaromyces Marneffei: a Systematic Review and Meta-analysis[J]. PLoS One, 2018, 13(4): 0195569-1-0195569-13.
LI X L, ZHENG Y Q, WU F Y, et al. Evaluation of Quantitative Real-Time PCR and Platelia Galactomannan Assays for the Diagnosis of Disseminated Talaromyces Marneffei Infection[J]. Med Mycol, 2020, 58(2): 181-186.
李凌华, 肖赛银, 何艳, 等.血清Mp1p抗原检测对艾滋病合并马尔尼菲蓝状菌病的诊断价值[J].中华传染病杂志, 2017, 35(3): 157-160.
孙弦, 刘栋华, 罗虹.马尔尼菲青霉病皮肤损害的临床与组织病理分析[J].中国皮肤性病学杂志, 2013, 27(2): 145-147.
PONGPOM M, VANITTANAKOM P, NIMMANEE P, et al. Adaptation to Macrophage Killing by Talaromyces Marneffei[J]. Future Science OA, 2017, 3(3): FSO215-1-FSO215-11.
谢浩锋, 郑晓林, 黄翔, 等.艾滋病合并马尔尼菲蓝状菌病的腹部CT及MRI征象分析[J].影像诊断与介入放射学, 2017, 26(4): 282-286.
钟洪伟.艾滋病合并马尔尼菲蓝状菌病的腹部CT及MRI征象分析[J].影像研究与医学应用, 2018(18): 53-54.
CHEN X Y, ANSTEY A V, BUGERT J J. Molluscum Contagiosum Virus Infection[J]. The Lancet Infectious Diseases, 2013, 13(10): 877-888.
朱元杰, 温海.原发性皮肤隐球菌病[J].中国真菌学杂志, 2007, 2(1): 43-44, 26.
杨松, 严晓峰.气管支气管结核的诊治进展[J].结核病与肺部健康杂志, 2017, 6(3): 282-285.
陈继川, 刘兆华, 姬长友, 等.咽喉结核32例报告[J].中华耳鼻咽喉科杂志, 2003, 38(2): 143-146.
于刚, 崔潇, 王铮, 等.咽喉部淋巴瘤的临床分析[J].中国耳鼻咽喉颅底外科杂志, 2016, 22(5): 388-392.
冯剑, 周涵, 董伟达.喉癌内镜诊断技术研究进展[J].山东大学耳鼻喉眼学报, 2019, 33(3): 129-133.
于晓敏.艾滋病合并肺结核的临床与CT表现分析及与其他肺部机会性感染的鉴别[D].广州: 南方医科大学, 2019.
AZAR M M, HAGE C A. Clinical Perspectives in the Diagnosis and Management of Histoplasmosis[J]. Clinics in Chest Medicine, 2017, 38(3): 403-415.
林斌, 刘劲松.肠道播散型荚膜组织胞浆菌病一例[J].临床内科杂志, 2012, 29(7): 483-484.
王澎, 张辉, 邵春红, 等.黑热病、组织胞浆菌病、马内菲青霉菌病病例比较及文献复习[J].中华检验医学杂志, 2015, 38(12): 874-876.
赵强, 王杏, 孙君, 等.艾滋病相关腹部淋巴瘤的CT表现及病理分析[J].放射学实践, 2019, 34(5): 535-539.
LE T, KINH N V, CUC N T K, et al. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis[J]. New England Journal of Medicine, 2017,376(24): 2329-2340.
FUNG S L, CHAU C H, YEW W W. Cardiovascular Adverse Effects during Itraconazole Therapy[J]. European Respiratory Journal, 2008, 32(1): 240.
SIRISANTHANA T, SUPPARATPINYO K, PERRIENS J, et al. Amphotericin B and Itraconazole for Treatment of Disseminated Penicillium Marneffei Infection in Human Immunodeficiency Virus-Infected Patients[J]. Clinical Infectious Diseases, 1998, 26(5): 1107-1110.
OUYANG Y Y, CAI S Q, LIANG H, et al. Administration of Voriconazole in Disseminated Talaromyces (Penicillium) Marneffei Infection: a Retrospective Study[J]. Mycopathologia, 2017,182(5-6): 569-575.
SUPPARATPINYO K, SCHLAMM H T. Voriconazole as Therapy for Systemic Penicillium Marneffei Infections in AIDS Patients[J]. The American Journal of Tropical Medicine and Hygiene, 2007, 77(2): 350-353.
LEI H L, LI L H, CHEN W S, et al. Susceptibility Profile of Echinocandins, Azoles and Amphotericin B Against Yeast Phase of Talaromyces Marneffei Isolated from HIV-Infected Patients in Guangdong, China[J]. European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37(6): 1099-1102.
袁锡华, 曹存巍.伏立康唑与两性霉素B治疗AIDS合并马尔尼菲蓝状菌病的疗效及安全性对比[J].广西医科大学学报, 2019, 36(2): 262-265.
戴婷婷, 胡林, 李逃明, 等.伏立康唑所致精神异常与其血浆谷浓度的相关性探讨[J].中国药学杂志, 2018, 53(5): 375-378.
陈月华, 董烈, 李静远.伏立康唑致精神异常的症状特点与相关因素探讨[J].中国医院用药评价与分析, 2020, 20(2): 246-248,251.
HALL C, HAJJAWI R, BARLOW G, et al. Penicillium Marneffei Presenting as an Immune Reconstitution Inflammatory Syndrome (IRIS) in a Patient with Advanced HIV[J]. Case Reports, 2013, 2013(jan28 1): bcr2012007555-1-bcr2012007555-4.
LIU X C, WU H, HUANG X J. Disseminated Penicillium Marneffei Infection with IRIS[J]. IDCases, 2015, 2(4): 92-93.
THANH N T, VINH L D, LIEM N T, et al. Clinical Features of Three Patients with Paradoxical Immune Reconstitution Inflammatory Syndrome Associated with Talaromyces Marneffei Infection[J]. Medical Mycology Case Reports, 2018, 19: 33-37.
SHELBURNE S A, MONTES M, HAMILL R J. Immune Reconstitution Inflammatory Syndrome: More Answers, more Questions[J]. Journal of Antimicrobial Chemotherapy, 2006, 57(2): 167-170.
CHARIYALERTSAK S, SUPPARATPINYO K, SIRISANTHANA T, et al. A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand[J]. Clinical Infectious Diseases, 2002, 34(2): 277-284.
CHAIWARITH R, FAKTHONGYOO A, PRAPARATTANAPAN J, et al. Itraconazole Vs Fluconazole as a Primary Prophylaxis for Fungal Infections in HIV-Infected Patients in Thailand[J]. Current HIV Research, 2011, 9(5): 334-338.
JIANG J J, QIN F X, MENG S R, et al. Effects of Cotrimoxazole Prophylaxis on Talaromyces Marneffei Infection in HIV/AIDS Patients Receiving Antiretroviral Therapy: a Retrospective Cohort Study[J]. Emerging Microbes & Infections, 2019, 8(1): 367-376.
SUPPARATPINYO K, PERRIENS J, NELSON K E, et al. A Controlled Trial of Itraconazole to Prevent Relapse of Penicillium Marneffei Infection in Patients Infected with the Human Immunodeficiency Virus[J]. New England Journal of Medicine, 1998,339(24): 1739-1743.
CHAIWARITH R, CHAROENYOS N, SIRISANTHANA T, et al. Discontinuation of Secondary Prophylaxis Against Penicilliosis Marneffei in AIDS Patients after HAART[J]. AIDS, 2007, 21(3): 365-367.